Fibromyalgia has a clear genetic component, but it is not caused by a single gene. If you have a parent, sibling, or child with fibromyalgia, you are roughly 8.5 times more likely to develop it than someone without that family history. The current scientific picture is one of inherited susceptibility: your genes can load the gun, but environmental factors typically pull the trigger.
How Strong Is the Family Risk?
The numbers from family studies are striking. Among blood relatives of someone with fibromyalgia, about 26% also have the condition. In a study focused specifically on siblings, the risk was just over 27%. And in children whose mothers had fibromyalgia, 28% eventually developed it themselves.
What makes these figures more compelling is what happens when you compare blood relatives to non-blood relatives living in the same household. People who shared the environment but not the DNA had a prevalence of only 19%, suggesting that genetics accounts for a meaningful chunk of risk beyond what shared lifestyle or stress exposure can explain.
One especially revealing study looked at parents and siblings of people with fibromyalgia. A full 52% had some clinical evidence of the condition, even though none had been previously diagnosed. Another 22% who appeared symptom-free still had abnormal muscle consistency similar to what’s found in fibromyalgia patients. That means nearly three-quarters of close relatives showed physical signs of susceptibility or early, unrecognized symptoms.
Which Genes Are Involved?
No single “fibromyalgia gene” exists. Instead, researchers have identified variations in several genes that each nudge the risk up by a small amount. The strongest candidates fall into a pattern: they influence how your brain and nervous system process pain signals, regulate mood, and respond to stress.
A region on chromosome 17 contains two key genes. One governs a serotonin transporter, the protein responsible for recycling serotonin after nerve cells use it. Variations in this gene have been linked to chronic pain conditions and to higher levels of depression and psychological distress in the same patients. The second gene in that region codes for a sensory channel involved in detecting temperature and pressure, which may help explain the heightened physical sensitivity that characterizes fibromyalgia.
Another well-studied gene controls an enzyme that breaks down several brain chemicals involved in pain modulation, mood, and the stress response. A specific variation in this gene has been correlated with a “high pain sensitivity” pattern in certain populations, as well as with greater depression, anxiety, and disability in women with fibromyalgia. Variations in a serotonin receptor gene have also been associated with the onset of fibromyalgia itself.
The largest genetic study to date, analyzing data from over 2.5 million individuals, identified 26 distinct regions of the genome that carry risk for fibromyalgia. The effect sizes were largely consistent across different study groups, reinforcing the idea that many small genetic contributions add up rather than one or two genes driving the condition.
Genes Alone Don’t Tell the Whole Story
Having genetic susceptibility does not guarantee you will develop fibromyalgia. Environmental triggers play an essential role, and the interaction between genes and environment appears to work partly through epigenetics, the process by which life experiences change how genes are read without altering the DNA sequence itself.
Chronic stress and early life trauma, for instance, can cause chemical modifications to a gene involved in the body’s stress response system. These modifications change how the system calibrates itself, potentially making a person more reactive to pain and stress for years afterward. Researchers have emphasized that studying genetic factors without accounting for personal life experiences can be deeply misleading, because the same gene variant may behave differently depending on what someone has lived through.
Common environmental triggers linked to fibromyalgia onset include physical injuries (especially to the spine or joints), infections, major surgery, prolonged psychological stress, and sleep disruption. In many cases, fibromyalgia appears to develop when one or more of these stressors hits a person whose genetic makeup already primes their nervous system toward heightened pain sensitivity.
Genetic Overlap With Related Conditions
If you have fibromyalgia, you may have noticed that irritable bowel syndrome, chronic fatigue syndrome, migraines, or mood disorders also run in your family. This is not a coincidence. A large Swedish study using national health data found that people with fibromyalgia carry elevated genetic risk not only for fibromyalgia itself, but also for IBS, chronic fatigue, depression, anxiety, several autoimmune conditions (particularly rheumatoid arthritis and Hashimoto’s thyroiditis), migraines, and sleep disorders.
Compared to IBS and chronic fatigue syndrome, fibromyalgia showed the most prominent and widely distributed genetic risk profile. IBS and chronic fatigue had more overlap with each other than either had with fibromyalgia, suggesting that while all three conditions share some genetic pathways, fibromyalgia also has unique genetic roots. Earlier research confirmed shared genetic liability among IBS, chronic widespread pain, migraines, and mood disorders, pointing to a partially overlapping biology across these conditions.
Can a Genetic Test Diagnose Fibromyalgia?
Not yet. Despite the progress in identifying risk genes, no genetic test is currently validated or recommended for diagnosing fibromyalgia. The 26 risk regions identified so far each contribute only a tiny amount of overall risk, and carrying any one variant does not reliably predict whether a person will develop the condition. Fibromyalgia remains a clinical diagnosis, made based on symptom patterns including widespread pain, fatigue, and cognitive difficulties.
The genetic research is valuable for a different reason: it confirms that fibromyalgia has a real biological basis rooted in how the nervous system processes pain and regulates stress chemicals. For people who have been told their symptoms are “all in their head,” the growing genetic evidence offers concrete validation that something measurable is different in their biology. The hope is that as the specific pathways become clearer, treatments can be better targeted to the underlying mechanisms rather than just managing symptoms on the surface.